The Flywheel medical imaging platform empowers healthcare innovation by unifying imaging data in one end-to-end platform that automates research workflows and makes data usable for AI development and secondary analysis. Scalable by design, Flywheel offers a way to securely aggregate, annotate, curate and analyze large amounts of imaging and video data for new discoveries. Our comprehensive solution allows pharmaceutical and biotechnology companies, academic medical centers, AI developers and medical device manufacturers to realize maximum value from their imaging data assets. With greater visibility and usability of their imaging data, parties across the medical landscape can accomplish more by accelerating research timelines, facilitating decision-making and laying the groundwork for audit-ready submissions.
Excelitas Technologies
Excelitas® is a leading provider of advanced, life-enriching technologies that make a difference, serving global market leaders in the life sciences, advanced industrial, next-generation semiconductor and avionics end markets. Headquartered in Pittsburgh, PA, USA, Excelitas is an essential partner in the design, development and manufacture of advanced technologies, offering leading-edge innovation in sensing, detection, imaging, optics and specialty illumination for customers worldwide. Excelitas is at the forefront of addressing many of the relevant megatrends impacting the world today, including precision medicine, industrial automation, artificial intelligence, and connected devices (IoT). Visit booth #3009 to see our Fusion UV® microwave UV curing systems and OmniCure® UV LED and lamp spot and area curing solutions for medical device assembly. Our industry recognized OmniCure spot curing systems feature closed-loop feedback, precise irradiance control and wavelength selection so manufacturers can achieve a controlled and repeatable UV assembly process for improved product yields and maximum reliability.
Evoq
EVOQ Technologies is advancing a function-first paradigm in clinical vision care through its SightGard™ platform, capturing objective retinal and neuro-visual performance using Android mobile device–based diagnostics. Its lead product, the Twilight™ Dark Adaptometer, enables rapid, standardized assessment of dark adaptation and night vision loss, supporting early detection and monitoring of retinal dysfunction across diseases including AMD, diabetic retinopathy, glaucoma, IRDs, and optic neuropathies. EVOQ focuses on repeatable, quantitative biomarkers that identify dysfunction before structural damage is visible, enabling earlier intervention and longitudinal patient monitoring. I-VIVO is EVOQ’s sister company dedicated to in vivo preclinical eye research. It develops and deploys novel structure and function instrumentation to capture high-precision data in small animal models. Capabilities include rodent contact lenses, small animal anesthesia, ERG and multi-spectral fundus imaging.
Etaluma, Inc.
Etaluma is a San Diego bio-imaging company offering incubator-based high performance multi-channel fluorescence microscopy. Our specialty is time-lapse live cell imaging in an incubator for days and even weeks to continuously visualize essential data for migration assays, wound healing, corneal epithelial cells, angiogenesis, and retinal cell behavior. Our short and simple optics path yields resolution and sensitivity that beats the big four. We have removed the oculars, the arc lamp, the filter wheels and the CCD from the traditional microscope; we instead use LEDs, CMOS cameras, and multi-bandpass filter sets to increase the sensitivity and resolution while allowing all of our models to be used in incubators, hypoxia chambers, and on your bench. Phase contrast, bright field and dark field transmitted modes are included. The LumaviewPro application is based on Python and is available as open source and includes a RESTful API.
Emmes
For over 40 years, Emmes has delivered scientifically rigorous, regulatory-compliant clinical research through a global team of 1,000+ professionals across the US, Europe, Canada, Latam, and India. As a full-service CRO, Emmes advances public health and biopharmaceutical innovation through disciplined science, operational excellence, and fact-based decision-making. With deep expertise in vaccines and infectious diseases, ophthalmology, immunology, neuroscience, and cell and gene therapy, Emmes has supported research in over 75 countries, contributing to 2,000+ clinical trials and 2,500+ publications. Continued investment in AI-enabled solutions, advanced technology platforms, innovative data management, and biostatistics/bioinformatics allows Emmes to deliver smarter, more efficient, and insight-driven research support tailored to evolving client needs.
8x R&D LLC
8x R&D is a research and product development company that brings novel technologies to the market through direct sales, joint development, technology transfer, and strategic partnerships. We can design and build custom imaging systems to address the needs of the early adopters of adaptive optics (AO) technology. Our instruments simultaneously acquire AO-assisted OCT and SLO images with cellular-level resolution in a compact footprint suitable for clinical operation. Customizable features include multi-offset aperture/phase gradient and confocal SLO, high-speed OCT (MHz), retinal tracking, controlled light stimulation from cone-level for optoretinography (ORG) to large area flicker for neurovascular coupling, fluorescence/autofluorescence/two photon, and multispectral analysis for human or small animal retinal imaging. We look forward to discussing your most demanding retinal imaging applications in early disease diagnosis, image guided therapies, and Oculomics.